Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1161/CIRCULATIONAHA.115.016006 http://scihub22266oqcxt.onion/10.1161/CIRCULATIONAHA.115.016006 C4582425!4582425!26371236     free     free     free       Circulation 2015 ; 132 (11): 1038-45 Nephropedia Template TP {{tp|p=26371236|t=2015. Drug Therapy for Heart Valve Diseases |pdf=|usr=}}{{26371236}} gab.com Text Drug Therapy for Heart Valve Diseases JO: Circulation http://www.kidney.de/pget.php?&tw=1&pmid=26371236 #FOAvip Valvular heart diseases (VHDs) are progressive. When not caused by acute comorbidities they are generally characterized by long asymptomatic phases during which hemodynamic severity may progress leading to morbidity and mortality. Treatment depends on VHD type and severity but when severe and symptomatic, usually involves mechanical intervention. Asymptomatic patients, and those who lack objective descriptors associated with high risk, are closely observed clinically with optimization of associated cardiovascular risk factors until surgical indications develop. Though often prescribed based on theory, no rigorous evidence supports pharmacological therapy in most chronic situations though drugs may be appropriate in acute valvular diseases, or as a bridge to surgery in severely decompensated patients. Herein, we examine evidence supporting drug use for chronic VHDs. Twit Text FOAVip Drug Therapy for Heart Valve Diseases ????Circulation http://www.kidney.de/pget.php?&tw=1&pmid=26371236 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26371236 #FOAvip English Wikipedia <ref>{{Cite pmid|26371236}}</ref> Drug Therapy for Heart Valve Diseases #MMPMID26371236 Borer JS; Sharma A Circulation 2015[Sep]; 132 (11): 1038-45 PMID26371236show ga Valvular heart diseases (VHDs) are progressive. When not caused by acute comorbidities they are generally characterized by long asymptomatic phases during which hemodynamic severity may progress leading to morbidity and mortality. Treatment depends on VHD type and severity but when severe and symptomatic, usually involves mechanical intervention. Asymptomatic patients, and those who lack objective descriptors associated with high risk, are closely observed clinically with optimization of associated cardiovascular risk factors until surgical indications develop. Though often prescribed based on theory, no rigorous evidence supports pharmacological therapy in most chronic situations though drugs may be appropriate in acute valvular diseases, or as a bridge to surgery in severely decompensated patients. Herein, we examine evidence supporting drug use for chronic VHDs. äDrug Therapy for Heart Valve Diseases (epmc).pdf DeepDyve Pubget Overpricing